Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1 Pt 1
|
pubmed:dateCreated |
1988-8-12
|
pubmed:abstractText |
We hypothesized that children with cyanotic congenital heart disease and moderate hypoxemia, as a result of erythrocytosis, and adequate iron stores would have low serum erythropoietin titers, low tissue oxygen delivery, and normal red cell 2,3-diphosphoglycerate (DPG) concentrations. We assessed hemoglobin levels, aortic oxygen saturation, iron stores, red cell 2,3-DPG, oxygen consumption, and systemic O2 transport in 19 hypoxemic patients, aged 3 months to 8 years. Low erythropoietin titers (less than 30 mU/dl) were found in 14 patients. Patients with high erythropoietin titers had lower Pao2 (36 +/- 7 vs 49 +/- 7 mm Hg, p less than 0.01), lower aortic saturation (68 +/- 12 vs 81 +/- 9%, p less than 0.01), and higher red cell 2,3-DPG (2.47 +/- 0.34 vs 3.23 +/- 0.73 mumol/ml, p less than 0.01). Aortic oxygen saturation higher than 80% was associated with a low erythropoietin titer and a hemoglobin level below that associated with hyperviscosity. The relationship between aortic oxygen saturation and hemoglobin concentration was strong (r = 0.77). These data suggest that for children less than 8 years of age, adequate compensation for moderate hypoxemia can occur with moderate increases in hemoglobin levels.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/2,3-Diphosphoglycerate,
http://linkedlifedata.com/resource/pubmed/chemical/Diphosphoglyceric Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Erythropoietin,
http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobins,
http://linkedlifedata.com/resource/pubmed/chemical/Iron,
http://linkedlifedata.com/resource/pubmed/chemical/Oxygen
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0002-8703
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
116
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
128-32
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3394615-2,3-Diphosphoglycerate,
pubmed-meshheading:3394615-Anoxia,
pubmed-meshheading:3394615-Child,
pubmed-meshheading:3394615-Child, Preschool,
pubmed-meshheading:3394615-Cyanosis,
pubmed-meshheading:3394615-Diphosphoglyceric Acids,
pubmed-meshheading:3394615-Erythropoietin,
pubmed-meshheading:3394615-Female,
pubmed-meshheading:3394615-Heart Defects, Congenital,
pubmed-meshheading:3394615-Hemoglobins,
pubmed-meshheading:3394615-Humans,
pubmed-meshheading:3394615-Infant,
pubmed-meshheading:3394615-Iron,
pubmed-meshheading:3394615-Male,
pubmed-meshheading:3394615-Oxygen,
pubmed-meshheading:3394615-Oxygen Consumption,
pubmed-meshheading:3394615-Polycythemia
|
pubmed:year |
1988
|
pubmed:articleTitle |
Erythropoietin in cyanotic heart disease.
|
pubmed:affiliation |
Children's Memorial Hospital, Chicago, IL 60614.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|